{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/5eb970e0375b18d778bf3565/5ecfd79b6f668a02b44363d2?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Biosciences with Alice McConnell of Speragen","description":"<p>This week host Dan Dillard is discussing lives impacted by rare genetic neurological diseases with Alice McConnell of Speragen. Alice is the Founder of Speragen, Inc. A niche pharmaceutical company focused on developing therapies for ultra-rare pediatric neurometabolic disorders. Prior to founding Speragen, Alice worked as a Civil Engineer and has a deep personal connection to her work in biosciences.</p><p><br></p><p>Learn more about the ACC Bioscience Incubator:</p><p><a href=\"https://sites.austincc.edu/incubator/\" rel=\"noopener noreferrer\" target=\"_blank\">https://sites.austincc.edu/incubator/</a></p><p><br></p><p>Learn more about Speragen:</p><p><a href=\"http://www.speragen.com/\" rel=\"noopener noreferrer\" target=\"_blank\">http://www.speragen.com/</a></p><p><br></p><p>Learn more about founding_media:</p><p><a href=\"https://foundingmedia.com/\" rel=\"noopener noreferrer\" target=\"_blank\">https://foundingmedia.com/</a></p>","author_name":"ACC Bioscience Incubator"}